Pevifoscorvir Sodium

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NamePevifoscorvir Sodium
Drug Alias NameALG-000184
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus capsid protein inhibitors
TargetsHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAligos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDmed Biopharmaceutical Co LtdXiamen Amoytop Biotech Co LtdNucleo Life Sciences Llc +[5] 
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A